At CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Mehdi Benlarbi
Advertisement
PhD Student at Univsersité de Montréal.
Articles by Mehdi Benlarbi
Advertisement
Latest Updated Articles
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Understanding the Importance of Bird Migration as it Relates to Avian Influenza
2
Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists
3
Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters
4
No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy
5
